| Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ... science 345 (6204), 1251086, 2014 | 1501 | 2014 |
| The allelic landscape of human blood cell trait variation and links to common complex disease WJ Astle, H Elding, T Jiang, D Allen, D Ruklisa, AL Mann, D Mead, ... Cell 167 (5), 1415-1429. e19, 2016 | 1162 | 2016 |
| Genetic drivers of epigenetic and transcriptional variation in human immune cells L Chen, B Ge, FP Casale, L Vasquez, T Kwan, D Garrido-Martín, S Watt, ... Cell 167 (5), 1398-1414. e24, 2016 | 646 | 2016 |
| Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics A Chamoli, AS Gosavi, UP Shirwadkar, KV Wangdale, SK Behera, ... Oral oncology 121, 105451, 2021 | 195 | 2021 |
| Azine-Based Receptor for Recognition of Hg2+ Ion: Crystallographic Evidence and Imaging Application in Live Cells M Suresh, AK Mandal, S Saha, E Suresh, A Mandoli, R Di Liddo, ... Organic Letters 12 (23), 5406-5409, 2010 | 163 | 2010 |
| Physiological characterization and stress-induced metabolic responses of Dunaliella salina isolated from salt pan A Mishra, A Mandoli, B Jha Journal of industrial microbiology and biotechnology 35 (10), 1093, 2008 | 124 | 2008 |
| ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia JHA Martens, A Mandoli, F Simmer, BJ Wierenga, S Saeed, AA Singh, ... Blood, The Journal of the American Society of Hematology 120 (19), 4038-4048, 2012 | 116 | 2012 |
| MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia KHM Prange, A Mandoli, T Kuznetsova, SY Wang, AM Sotoca, ... Oncogene 36 (23), 3346-3356, 2017 | 99 | 2017 |
| CBFB–MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv (16) acute … A Mandoli, AA Singh, P Jansen, ATJ Wierenga, H Riahi, G Franci, ... Leukemia 28 (4), 770-778, 2014 | 86 | 2014 |
| The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t (8; 21) AMLs A Mandoli, AA Singh, KHM Prange, E Tijchon, M Oerlemans, R Dirks, ... Cell reports 17 (8), 2087-2100, 2016 | 67 | 2016 |
| E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer K Teo, L Gómez-Cuadrado, M Tenhagen, A Byron, M Rätze, ... Scientific reports 8 (1), 15454, 2018 | 64 | 2018 |
| Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization T Kuznetsova, SY Wang, NA Rao, A Mandoli, JHA Martens, N Rother, ... Genome biology 16, 1-15, 2015 | 64 | 2015 |
| The oncofusion protein FUS–ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t (16; 21) acute myeloid leukemia AM Sotoca, KHM Prange, B Reijnders, A Mandoli, LN Nguyen, ... Oncogene 35 (15), 1965-1976, 2016 | 48 | 2016 |
| Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma WF Ooi, AM Nargund, KJ Lim, S Zhang, M Xing, A Mandoli, JQ Lim, ... Gut 69 (6), 1039-1052, 2020 | 44 | 2020 |
| Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome G Iacono, A Dubos, H Méziane, M Benevento, E Habibi, A Mandoli, F Riet, ... Nucleic Acids Research 46 (10), 4950-4965, 2018 | 41 | 2018 |
| MEIS2 is an oncogenic partner in AML1-ETO-positive AML NM Vegi, J Klappacher, F Oswald, MA Mulaw, A Mandoli, VN Thiel, ... Cell reports 16 (2), 498-507, 2016 | 41 | 2016 |
| Joosten S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ... LAB, Wijmenga, C., Martens, JHA, Xavier, RJ, Logie, C., Netea, MG, and …, 2014 | 41 | 2014 |
| Chromatin-based classification of genetically heterogeneous AMLs into two distinct subtypes with diverse stemness phenotypes G Yi, ATJ Wierenga, F Petraglia, P Narang, EM Janssen-Megens, ... Cell reports 26 (4), 1059-1069. e6, 2019 | 37 | 2019 |
| Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392 F De Bellis, V Carafa, M Conte, D Rotili, F Petraglia, F Matarese, ... Cancer research 74 (8), 2328-2339, 2014 | 35 | 2014 |
| DNA binding and cleavage properties of a newly synthesised Ru (II)-polypyridyl complex A Ghosh, A Mandoli, DK Kumar, NS Yadav, T Ghosh, B Jha, JA Thomas, ... Dalton Transactions, 9312-9321, 2009 | 32 | 2009 |
